Arterial hypertension and metabolic syndrome

Metabolic syndrome is a risk factor for development of cardiovascular diseases. Arterial hypertension is one of components of metabolic syndrome. Adipous tissue is not only a depot for energetic compounds, but is an active endocrine organ synthetizing biologically active substances that facilitate development of AH. Patients with AH and obesity are in the high cardiovascular risk group and demand effective combination antihypertension therapy. One of such drugs is the fixed combination of azilsartan medoxomil and chlorthalidone, which safety and efficacy are confirmed by various trials.